Macular Disease Foundation Australia logo

    Research news

    Research News

    The latest funding round now brings MDFA’s commitment to macular disease research to $5.8 million across 35 projects since 2011.

    Read more

    Most recent

    Image of a senior man eating a bowl of salad

    Anti-VEGF treatment not linked to stroke

    Anti-VEGF therapy is not linked to an increased risk of stroke, myocardial infarction or death, according to a new report.

    New genes linked to AMD

    Scientists have found three new genes associated with age-related macular degeneration (AMD).

    image of pills

    Statins and diabetic eye disease

    Research shows statin use could be linked to lower rates of diabetic retinopathy.

    Two men chatting about a book

    Treatment non-adherence concern

    Up to a quarter of anti-VEGF patients being treated for AMD and diabetic macular oedema are lost to follow-up.

    Lady with a coffee cup and mobile

    Retinal implant trial

    An electronic retinal implant to treat age-related macular degeneration, has shown excellent results in a small clinical trial.

    New WA Research Centre for Juvenile Macular Disease

    MDFA Research Grant recipient Dr Fred Chen will head a new Centre of Research Excellence in juvenile macular disease.

    New sight saving resources for residential aged care

    A report and new digital training tools aim to improve understanding of eye health and vision loss in Australia’s residential aged care facilities.

    MDFA position statement re 2RT laser.

    MDFA position statement re 2RT laser.

    Is the rate of AMD falling?

    A US study suggests that the rate of AMD at specific ages has fallen by about 60% each successive generation. But is that the case?

    Loading...